Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.38 |
| ▸ | TSHR | P16473 | 2/20 | 0.38 |
| ▸ | LMNA | P02545 | 1/20 | 0.38 |
| ▸ | GLA | P06280 | 1/20 | 0.35 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.34 |
| ▸ | HTT | P42858 | 1/20 | 0.34 |
| ▸ | HSD11B1 | P28845 | 4/20 | 0.34 |
| ▸ | POLB | P06746 | 1/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | ATM | Q13315 | 1/20 | 0.33 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.33 |
| ▸ | PKM | P14618 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19601626 | 0.81 | ALDH1A1 (0.36) | ALDH1A1TSHRLMNAKDM4EPOLB | |
| SCHEMBL19937894 | 0.79 | ALDH1A1 (0.35) | ALDH1A1LMNAKDM4EMEN1KMT2A | |
| SCHEMBL25515111 | 0.79 | — | — | |
| SCHEMBL26375621 | 0.79 | ALDH1A1 (0.37) | ALDH1A1TSHRLMNAKDM4EPOLB | |
| SCHEMBL25514953 | 0.77 | ALDH1A1 (0.42) | ALDH1A1TSHRLMNAHSD11B1POLB | |
| SCHEMBL19601022 | 0.74 | ALDH1A1 (0.43) | ALDH1A1TSHRLMNAKDM4EPOLB | |
| SCHEMBL1075076 | 0.68 | ALDH1A1 (0.49) | ALDH1A1TSHRLMNAKDM4EHTT | |
| SCHEMBL26061885 | 0.67 | PKM (0.33) | ALDH1A1KDM4EHTTPOLBKMT2A | |
| SCHEMBL8533984 | 0.66 | ALDH1A1 (0.50) | ALDH1A1TSHRLMNAGLAKDM4E | |
| SCHEMBL4474354 | 0.66 | ALDH1A1 (0.47) | ALDH1A1TSHRLMNAGLAKDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230161243-A1 | SALT, ACID GENERATOR, RESIN, RESIST COMPOSITION AND METHOD FOR PRODUCING RESIST PATTERN | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2023-05-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230161243-A1 | SALT, ACID GENERATOR, RESIN, RESIST COMPOSITION AND METHOD FOR PRODUCING RESIST PATTERN | RER1, ASIC1, REN | ALDH1A1 1360/4885TSHR 2717/4885LMNA 4153/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.